Loading
A phase 3 trial of Methotrexate and Pentostatin in Acute lymphoblastic leukaemia and Leukaemia, run by St. Jude Children's Research Hospital, completed.
Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies is a phase 3 interventional study registered as NCT01188798 by St. Jude Children's Research Hospital, with 6 participants recorded, started 2010-09 and reaching its primary completion in 2012-02. Interventions recorded: Methotrexate, Pentostatin. Conditions recorded: Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Chronic Myelocytic Leukemia, Hodgkin's Disease, Myelodysplastic Syndrome.
Linked to the drug Pentostatin because the registry names it among its interventions and Acute lymphoblastic leukaemia and Leukaemia among its conditions. Registry record only: no result has been read by an editor.
Shares Pentostatin and the tag pipeline.
Shares Leukaemia (all types), Acute lymphoblastic leukaemia and the tag pipeline.
Shares Pentostatin and the tag pipeline.
Shares Acute lymphoblastic leukaemia and the tag pipeline.
Shares Acute lymphoblastic leukaemia and the tag pipeline.
Shares Acute lymphoblastic leukaemia and the tag pipeline.
Shares Acute lymphoblastic leukaemia and the tag pipeline.
Shares Methotrexate, Leukaemia (all types), Acute lymphoblastic leukaemia and the tag pipeline.